Advertisement
Singapore markets closed
  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     
  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • FTSE 100

    7,838.94
    -38.11 (-0.48%)
     
  • Bitcoin USD

    64,839.21
    +3,243.92 (+5.27%)
     
  • CMC Crypto 200

    1,333.31
    +20.68 (+1.60%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • Dow

    37,775.38
    +22.07 (+0.06%)
     
  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     
  • Gold

    2,395.70
    -2.30 (-0.10%)
     
  • Crude Oil

    82.30
    -0.43 (-0.52%)
     
  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     
  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     
  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Dow snaps 8-day winning streak as rates spike

The Dow can’t make it nine in a row as rising yields stop the winning streak. Plus, Facebook and Twitter are cleaning up their acts. We have the latest. And, we go whale — What were the biggest fund managers holding last quarter? Plus, Lee Munson is here to break down the markets and give us his advice for investors this summer. Hint: its one word. Catch The Final Round at 3:55 ET p.m. with Jen Rogers and Yahoo Finance markets correspondent Myles Udland.

Winners and losers

Stocks in the red include Wynn Resorts as two board members, including one who was investigating sexual-misconduct allegations against former Chief Executive Steve Wynn, will leave their posts Amazon, as the e-commerce giant and other Seattle companies will be hit by a new tax on the city’s biggest businesses; and Home Depot, as the company attributed a slow start this year to colder weather which weighed on sales of spring products like patio furniture and lawn mowers.

Stocks in the green include Ulta, as Oppenheimer upgraded the beauty store chain from Perform to Outperform, calling it a top beauty pick; CF Industries, as fertilizer producers’ estimates and stock price targets are raised at Stifel to $43 from $37; and Inovio Pharmaceuticals, as their HIV vaccine shows positive effects in an early-stage study.